Actions of Parathyroid Hormone on the Vasculature and Cardiovascular System

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 657-663

  Fitzpatrick, Lorraine A ^a   Bilezikian, John P ^b   Silverberg, Shonni J ^b  

^a GLAXOSMITHKLINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77649134817     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00002-1     Document Type: Chapter

References (54)

1. E.G. Almqvist, A.G. Bondeson, L. Bondeson, A. Nissborg, P. Smedgard and S.E. Svensson (2002) Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 132 1126-1132.
2. G. Barletta, M. Laura De Feo, R. Del Bene, C. Lazzeri, S. Vecchiarino, G. La Villa, M.L. Brandi and F. Franchi (2000) Cardiovascular effects of parathyroid hormone: A study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85 1815-1821.
3. M. Baykan, C. Erem, T. Erdogan, A. Hachihasanoglu, O. Gedikli, A. Kiris, M. Kucukosmanoglu, O. Halil and S. Celik (2007) Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int. J. Cardiovasc. Imaging 23 323-328.
4. E. Bogin, S.G. Massry and I. Harary (1981) Effects of parathyroid hormone on rat heart cells. J. Clin. Invest. 67 1215-1227.
5. D.E. Cole, R. Vieth, H.M. Trang, B.Y. Wong, G.N. Hendy and L.A. Rubin (2001) Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol. Genet. Metab. 72 168-174.
6. J.B. Collip and E.P. Clark (1925) Further studies on parathyroid hormone. J. Biol. Chem. 66 485-507.
7. E. Delfini, L. Petramala, C. Caliumi, D. Cotesta, G. De Toma, G. Cavallaro, G. Panzironi, D. Diacinti, S. Minisola, E. D'Erasmo, G.F. Mazzuoli and C. Letizia (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56 30-36.
8. D.J. Dipette, W. Christenson, M.A. Nickols and G.A. Nickols (1992) Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology 130 2045-2051.
9. F. Fallo, G. Cella, A. Casonato, M. Ermani, R. Vettor, S. Zaneela and F. Lumachi (2006) Biochemical markers of endothelial activation in primary hyperparathyroidism. Horm. Metab. Res. 38 125-129.
10. D. Fliser, E. Franek, P. Fode, A. Stefanski, C.P. Schmitt, M. Lyons and E. Ritz (1997) Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol.
11. C. Gennari, R. Nami and S. Gonnelli (1995) Hypertension and primary hyperparathyroidism: Role of the adrenergic and plasma renin angiotensin systems. Miner. Electrolyte Metab. 21 51-77.
12. E. Hagstrom, E. Lundgren, J. Rastad and P. Hellman (2006) Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol. 155 33-39.
13. M. Hara, Y. Liu, L. Zhen, I.S. Cohen, H. Yu, P. Danilo, K. Ogino, J.P. Bilezikian and M.R. Rosen (1997) The positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are due to increases in the current If, and the slope of the pacemaker potential. Circulation 96 3704-3709.
14. M. Hara, Y.M. Liu, I.S. Cohen, H. Yu, P. Danilo, K. Ogino, J.P. Bilezikian and M.R. Rosen (1995) Parathyroid hormone and related peptide modulate impulse initiation and pacemaker current in the heart. Circulation 92 8-639.
15. G.M. Hedback and A.S. Oden (2002) Cardiovascular disease, hypertension, and renal function in primary hyperparathyroidism. J. Intern. Med. 251 476-483.
16. H.N. Hutler, J.C. Melby, J.C. Peterson and C.R. Cooke (1986) Chronic continuous PTH infusion results in hypertension in normal subjects. J. Clin. Hypertens. 2 360-370.
17. O. Ifudu, J.J. Matthew, L.J. Macey, J.S. Hong, N. Sumrani, B.G. Sommer and E.A. Friedman (1998) Parathyroidectomy does not correct hypertension in patients on maintenance hemodialysis. Am. J. Nephrol. 18 28-34.
18. R. Jorde, J. Sundsfjord, E. Haug and K.H. Bønaa (2000) Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 35 1154-1159.
19. R. Jorde, J. Sundsfjord, P. Fitzgerald and K.H. Bønaa (1999) Serum calcium and cardiovascular risk factors and diseases: The Tromso study. Hypertension 34 484-490.
20. E. Kamycheva, J. Sundsfjord and R. Jorde (2004) Serum parathyroid hormone levels predict coronary heart disease: The Tromso Study. Eur. J. Cardiovasc. Prev. Rehabil. 11 69-74.
21. M. Kosch, M. Hausberg, K. Vormbrock, et al. (2000) Impaired flow-mediated vasodilatation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res. 47 813-818.
22. P. Lakatos, A. Tatra, J. Foldes, C. Harvath, J. Mako and P.H. Stern (1996) Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism. Calcif. Tissue Int. 58 70-71.
23. B.G. Leifsson and B. Ahren (1996) Serum calcium and survival in a large health-screening program. J. Clin. Endocrinol. Metab. 81 2149-2153.
24. L. Lind, E. Skarfors, L. Berglund, H. Lithell and S. Ljunghall (1997) Serum calcium: A new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J. Clin. Epidemiol. 50 967-973.
25. S. Ljunghall, C. Abela, H. Frank., et al. (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J. Clin. Endocrinol. Metab. 82 106-112.
26. L.L.S. Mok, G.A. Nichols, J.C. Thompson and C.W. Cooper (1989) Parathyroid hormone as a smooth muscle relaxant. Endocr. Rev. 10 420-436.
27. L. Morfis, P. Smerdely and L.G. Howes (1997) Relationship between serum parathyroid hormone levels in the elderly and 24h ambulatory blood pressures. J. Hypertens. 15 1271-1276.
28. G.A. Nickols, A.D. Nana, M.A. Nickols, D.J. DiPette and G.K. Asimakis (1989) Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology 125 834-841.
29. I.L. Nilsson, J. Aberg, J. Rastad and L. Lind (1999) Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126 1049-1055.
30. I.L. Nilsson, J. Aberg, J. Rastad and L. Lind (2000) Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism – effects of parathyroidectomy. Surgery 128 895-902.
31. I.L. Nilsson, J. Aberg, J. Rastad and L. Lind (2005) Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery 137 632-638.
32. I.L. Nilsson, J. Aberg, J. Rastad and L. Lind (2003) Circadian cardiac autonomic nerve dysfunction in primary hyperparathyroidism improves after parathyroidectomy. Surgery 134 1013-1019.
33. I.L. Nilsson, J. Rastad, K. Johansson and L. Lind (2001) Endothelial vasodilatatory function and blood pressure response to local and systemic hypercalcemia. Surgery 130 986-990.
34. I.L. Nilsson, C. Wadsten, L. Brandt, J. Rastad and A. Ekbom (2004) Mortality in sporadic primary hyperparathyroidism: Nationwide cohort study of multiple parathyroid gland disease. Surgery 136 981-987.
35. V. Nuzzo, L. Tauchmanova, F. Fonderico, R. Trotta, M.R. Fittipaldi, D. Fontana, R. Rossi, G. Lombardi, B. Trimarco and G. Lupoli (2002) Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur. J. Endocrinol. 147 453-459.
36. C.G. Ogard, M.S. Engholm, T.P. Almdal and H. Vestergaard (2004) Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977–1993 in Denmark. World J. Surg. 28 108-111.
37. C.G. Ogard, S.B. Sondergaard, H. Vestergaard, H. Jakobsen and S.L. Nielsen (2005) Myocardial perfusion defects and the left ventricular ejection fraction disclosed scintigraphy in patients with primary hyperparathyroidism. World J. Surg. 29 914-916.
38. K. Ogino, D. Burkhoff and J.P. Bilezikian (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136 3024-3030.
39. M. Palmer, H.O. Adami, R. Bergstrom and G. Akerstrrom (1987) Mortality after surgery for PHPT. Surgery 102 1-7.
40. A. Piovesan, N. Molineri, F. Casasso, I. Emmolo, G. Ugliengo, F. Cesario, et al. (1999) Left ventricular hypertrophy in primary hyperparathyroidism: Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf.) 50 321-328.
41. A. Roca-Cusachs, D.J. Dipette and G. Nickols Ga. (1991) Regional and systemic hemodynamic effects of parathyroid hormone-related protein: Preservation of cardiac function and coronary and renal flow with reduced blood pressure. J. Pharmacol. Exp. Ther. 256 110-118.
42. M.R. Rubin, M.S. Maurer, D.J. McMahon, J.P. Bilezikian and S.J. Silverberg (2005) Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrin. Metabol. 90 3326-3330.
43. M.R. Rubin, T. Rundek, D.J. McMahon, H-S. Lee, R.L. Sacco and S.J. Silverberg (2007) Carotid artery plaque thickness is associated with increased serum calcium levels: The Northern Manhattan study. Atherosclerosis 194 426-432.
44. J.J. Sancho, J. Rouco, R. Riera-Vidal and A. Sitges-Serra (1992) Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J. Surg. 16 732-735.
45. A.K. Sangal, M. Kevwitch, D.S. Rao and J. Rival (1989) Hypomagnesemia and hypertension in primary hyperparathyroidism. South Med. J. 82 1116-1118.
46. R. Schleiffer (1992) Parathyroid hormone and genetic hypertension. Int. J. Cardiol. 35 303-310.
47. K.-D. Schluter and H.M. Piper (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Circ. Res. 37 34-41.
48. Shimoyama, M., Ogino, K., Burkhoff, D., Bilezikian, J. P., and Hisatome, I. (1998a). Signal transduction pathways and the chronotropic actions of PTH in isolated rat hearts. The Endocrine Society, 80th Annual Meeting, P–592.
49. M. Shimoyama, K. Ogino, S. Taniguchi, A. Yoshida, I. Hisatome, J.P. Bilezikian and C. Shigemasa (1998) Signal transduction pathways and chronotropic actions of PTH and its fragments in isolated, perfused rat hearts. Bone 23(Suppl. 5), T197.
50. J.C. Smith, M.M. Page, R. John, M.H. Wheeler, J.R. Cockcroft, M.F. Scanlon and J.S. Davis (2000) Augmentation of central arterial pressure in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85 3515-3519.
51. T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, et al. (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J. Clin. Endocrinol. Metab. 82 106-112.
52. T.E. Tenner Jr., S. Ramanadham, M.C.M. Yang and P.K. Pang (1983) Chronotropic ations of bPTH-(1-34) in the right atrium of the rat. Can. J. Physiol. Pharmacol. 61 1162-1167.
53. H. Vestergaard and L.O. Kristensen (2002) Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: Evidence of increased morbidity from cardiovascular disease. World J. Surg. 26 657-660.
54. R.A. Wermers, S. Khosla, E.J. Atkinson, et al. (1998) Survival after diagnosis of PHPT: A population-based study. Am. J. Med. 104 115-122.